Trial
NCT05016622
Booster Dose Trial
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Montefiore Medical Center
Collaborators
Albert Einstein College of Medicine; National Cancer Institute (NCI); The Leukemia and Lymphoma Society
Condition
Cancer
Intervention
BNT162b2 vaccine
Why stopped
Due to decreased level of engagement and available funding, PI determined it appropriate to close the study prior to visit occurring. IRB approved.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-31